Patents by Inventor Timm Trenktrog

Timm Trenktrog has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
    Publication number: 20230218532
    Abstract: A solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD by lyophilizing a flash frozen stock solution of LSD and excipients, including a non-gelling matrix former, filler, and binder in a pre-formed mold, and forming an orally disintegrating tablet. A method of treating an individual by administering a solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet and treating the individual.
    Type: Application
    Filed: April 3, 2023
    Publication date: July 13, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Timm TRENKTROG, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, Lisa Marie GARRETT
  • LYOPHILIZED ORALLY DISINTEGRATING TABLET FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
    Publication number: 20230122949
    Abstract: A solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD by lyophilizing a flash frozen stock solution of LSD and excipients, including a non-gelling matrix former, filler, and binder in a pre-formed mold, and forming an orally disintegrating tablet. A method of treating an individual by administering a solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet and treating the individual.
    Type: Application
    Filed: December 7, 2022
    Publication date: April 20, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Timm TRENKTROG, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, Lisa Marie GARRETT
  • IMMEDIATE RELEASE FORMULATIONS OF d-LYSERGIC ACID DIETHYLAMIDE FOR THERAPEUTIC APPLICATIONS
    Publication number: 20230075847
    Abstract: A solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet. A method of making a solid oral immediate release formulation of LSD by lyophilizing a flash frozen stock solution of LSD and excipients, including a non-gelling matrix former, filler, and binder in a pre-formed mold, and forming an orally disintegrating tablet. A method of treating an individual by administering a solid oral immediate release formulation of LSD, wherein the composition is produced by lyophilization of a feedstock in a pre-formed mold to form an orally disintegrating tablet and treating the individual.
    Type: Application
    Filed: August 17, 2022
    Publication date: March 9, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Peter MACK, Timm TRENKTROG, Dustin MELTON, Bethany Amber DOTY, Jon SCHROEDER, Lisa Marie GARRETT
  • DISPERSIBLE TABLET
    Publication number: 20130023547
    Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide.
    Type: Application
    Filed: September 27, 2012
    Publication date: January 24, 2013
    Inventors: Lovelace HOLMAN, Timm TRENKTROG
  • Dispersible bosentan tablet
    Patent number: 8309126
    Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: November 13, 2012
    Assignee: Actelion Pharmaceuticals, Ltd.
    Inventors: Lovelace Holman, Timm Trenktrog
  • DISPERSIBLE BOSENTAN TABLET
    Publication number: 20110245281
    Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide.
    Type: Application
    Filed: June 7, 2011
    Publication date: October 6, 2011
    Inventors: Lovelace HOLMAN, Timm Trenktrog
  • Dispersible bosentan tablet
    Patent number: 7959945
    Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide.
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: June 14, 2011
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Lovelace Holman, Timm Trenktrog
  • Dispersible Bosertan Tablet
    Publication number: 20080193528
    Abstract: The invention relates to dispersible tablets comprising the compound 4-tert-butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-(pyrimidin-2-yl)-pyrimidin-4-yl]-benzenesulfonamide.
    Type: Application
    Filed: May 15, 2006
    Publication date: August 14, 2008
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Lovelace Holman, Timm Trenktrog